Similar results were shown by Sinoquet et al., where OS was significantly worse in NSCLC patients with PD-L1-CTCs and particularly in patients with PD-L1+CTCs compared with patients without CTCs. This evidence concerns the gene CD274 and non-small cell lung carcinoma.